Stephanie Krebs insider trades
Open-market stock purchases and sales by Stephanie Krebs, Chief Business Officer at Sensei Biotherapeutics, Inc, from SEC Form 4 filings since Nov 1, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- SNSE Sensei Biotherapeutics, Inc: other filings, last Feb 14, 2025